Glaukos Corporation to Release Fourth Quarter and Full Year 2017 Financial Results after Market Close on February 28
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, plans to release fourth quarter and full year 2017 financial results after the market close on Wednesday, February 28, 2018. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PST (4:30